Get the Stockscreener App
0.1102
0.27%
0.0003
Cellyan Biotechnology Co Ltd Stock (HKPD) Forecast
The Cellyan Biotechnology Co Ltd (HKPD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.6918, representing a +527.76% increase from the current price of $0.1102. The highest analyst price target is $0.6422, and the lowest is $0.7414.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HKPD Price Target
Average 0.6891
(+525.31% Upside)
Is Cellyan Biotechnology Co Ltd (HKPD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.68 | Neutral |
| STOCH(9,6) | 71.68 | Neutral |
| STOCHRSI(14) | 91.80 | Sell |
| MACD(12,26) | -0.024 | Buy |
| ADX(14) | 58.16 | Sell |
| William %R | -33.33 | Neutral |
| CCI(14) | 12.52 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1068
Buy
|
0.1094
Buy
|
| MA20 |
0.111
Sell
|
0.1213
Sell
|
| MA50 |
0.2135
Sell
|
0.1957
Sell
|
| MA100 |
0.3198
Sell
|
0.3081
Sell
|
| MA200 |
0.5026
Sell
|
0.5173
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, HKPD could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on HKPD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.68 indicates that HKPD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.68 indicates that HKPD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.8 indicates that HKPD is oversold. This suggests that HKPD price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 58.16 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 12.52 indicates that HKPD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HKPD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cellyan Biotechnology Co Ltd financial reports and earnings history, Cellyan Biotechnology Co Ltd (HKPD) stock could reach $1.3813 by 2030, $5.6114 by 2040 and $8.0235 by 2050. See the projected annual prices until 2050 of the Cellyan Biotechnology Co Ltd stock below:
- Cellyan Biotechnology Co Ltd (HKPD) is expected to reach an average price of $9.6288 in 2035, with a high prediction of $10.13 and a low estimate of $9.7894. This indicates an $8,638% rise from the last recorded price of $0.1102.
- Cellyan Biotechnology Co Ltd (HKPD) stock is projected to chart a bullish course in 2040, with an average price target of $4.8775, representing an $4,326% surge from its current level. The forecast ranges from a conservative $4.9156 to a sky-high $5.6114.
- Our analysts predict Cellyan Biotechnology Co Ltd (HKPD) to jump 16,647% by 2045, soaring from $18.63 to an average price of $18.46, potentially reaching $18.82. While $18.63 is the low estimate, the potential upside is significant.
- Cellyan Biotechnology Co Ltd (HKPD) stock is expected to climb by 2050, reaching an average of $7.0741, a $6,319% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.0235 and $7.0831, respectively, highlighting the market's uncertainty.
Cellyan Biotechnology Co Ltd Stock (HKPD) Year by Year Forecast
Cellyan Biotechnology Co Ltd Stock (HKPD) Price Forecast for 2026
The predicted value for Cellyan Biotechnology Co Ltd (HKPD) in 2026 is set at an average of $0.5464. Estimates vary from a peak of $1.053 to a trough of $0.0398, indicating an +395.82% surge from the present price of $0.1102.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.888 | $0.7414 | $0.6422 | +705.80% |
| December, 2026 | $1.1238 | $1.2076 | $1.053 | +919.76% |
Cellyan Biotechnology Co Ltd Stock (HKPD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cellyan Biotechnology Co Ltd (HKPD) is $0.6891, with a high forecast of $1.1971 and a low forecast of $0.1811. This indicates an +525.31% increase from the last price of $0.1102.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3887 | $1.2982 | $1.1492 | +1,160% |
| February, 2027 | $1.307 | $1.3016 | $1.1971 | +1,086% |
| March, 2027 | $0.554 | $0.574 | $1.0424 | +402.68% |
| April, 2027 | $0.6755 | $0.6497 | $0.6261 | +513.02% |
| May, 2027 | $0.7725 | $0.6162 | $0.7116 | +601.03% |
| June, 2027 | $0.2441 | $0.7141 | $0.8259 | +121.53% |
| July, 2027 | $0.1357 | $0.3457 | $0.2703 | +23.15% |
| August, 2027 | $0.1327 | $0.1811 | $0.2374 | +20.42% |
| September, 2027 | $0.4543 | $0.3081 | $0.1389 | +312.25% |
| October, 2027 | $0.636 | $0.4935 | $0.5681 | +477.12% |
| November, 2027 | $0.4143 | $0.4874 | $0.5153 | +275.93% |
| December, 2027 | $0.3155 | $0.3646 | $0.3483 | +186.27% |
Cellyan Biotechnology Co Ltd Stock (HKPD) Price Forecast for 2028
In 2028, Cellyan Biotechnology Co Ltd (HKPD) is projected to reach an average price of $1.762, with a high projection of $3.5184 and a low estimate of $0.00571. This indicates an +1,499% rise from the last price of $0.1102.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3565 | $0.4118 | $0.3653 | +223.47% |
| February, 2028 | $0.2711 | $0.3831 | $0.3477 | +145.96% |
| March, 2028 | $0.1096 | $0.1477 | $0.1284 | -0.51% |
| April, 2028 | $0.1712 | $0.2046 | $0.1266 | +55.39% |
| May, 2028 | $0.1932 | $0.2066 | $0.1879 | +75.34% |
| June, 2028 | $0.1096 | $0.104 | $0.0996 | -0.53% |
| July, 2028 | $0.0046 | $0.00571 | $0.0681 | -95.82% |
| August, 2028 | $0.1399 | $0.0072 | $0.1646 | +26.95% |
| September, 2028 | $0.043 | $0.06 | $0.1064 | -60.99% |
| October, 2028 | $3.1921 | $0.0342 | $2.976 | +2,797% |
| November, 2028 | $3.6652 | $3.2828 | $3.3302 | +3,226% |
| December, 2028 | $3.6584 | $3.6076 | $3.5184 | +3,220% |
Cellyan Biotechnology Co Ltd Stock (HKPD) Price Forecast for 2029
The 2029 price forecast for Cellyan Biotechnology Co Ltd Stock (HKPD) is $2.4603 on average, with a high prediction of $3.4415 and a low estimate of $1.479. This represents an +2,133% increase from the previous price of $0.1102.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.4123 | $3.6298 | $3.4415 | +2,996% |
| February, 2029 | $3.1855 | $3.3461 | $3.394 | +2,791% |
| March, 2029 | $2.5587 | $2.6479 | $3.0163 | +2,222% |
| April, 2029 | $2.4827 | $2.5426 | $2.6017 | +2,153% |
| May, 2029 | $2.5456 | $2.5535 | $2.5642 | +2,210% |
| June, 2029 | $2.249 | $2.463 | $2.4667 | +1,941% |
| July, 2029 | $1.983 | $1.8122 | $1.9506 | +1,699% |
| August, 2029 | $1.7462 | $1.8162 | $1.7947 | +1,485% |
| September, 2029 | $1.8317 | $1.7678 | $1.7144 | +1,562% |
| October, 2029 | $1.749 | $1.8777 | $1.904 | +1,487% |
| November, 2029 | $1.5476 | $1.618 | $1.6999 | +1,304% |
| December, 2029 | $1.4705 | $1.479 | $1.4381 | +1,234% |
Cellyan Biotechnology Co Ltd Stock (HKPD) Price Forecast for 2030
Cellyan Biotechnology Co Ltd Stock (HKPD) is expected to reach an average price of $3.0518 in 2030, with a high forecast of $5.9389 and a low forecast of $0.1646. This signifies an +2,669% surge from the last price of $0.1102.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2537 | $1.3532 | $1.3813 | +1,038% |
| February, 2030 | $1.0069 | $1.2209 | $1.2653 | +813.70% |
| March, 2030 | $0.9177 | $0.9424 | $0.9487 | +732.74% |
| April, 2030 | $0.8791 | $0.8783 | $0.8387 | +697.70% |
| May, 2030 | $0.6576 | $0.7204 | $0.7858 | +496.77% |
| June, 2030 | $0.4579 | $0.5563 | $0.558 | +315.54% |
| July, 2030 | $0.3211 | $0.3344 | $0.4014 | +191.38% |
| August, 2030 | $0.3458 | $0.3506 | $0.426 | +213.78% |
| September, 2030 | $5.1694 | $0.1646 | $4.9094 | +4,591% |
| October, 2030 | $5.6842 | $5.5356 | $5.542 | +5,058% |
| November, 2030 | $6.1689 | $5.8903 | $5.9389 | +5,498% |
| December, 2030 | $5.8604 | $5.9498 | $5.8875 | +5,218% |
7.72%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):